Your browser doesn't support javascript.
loading
Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome.
Chen, Junyu; Zou, Cong; Guan, Hongbing; Zhou, Xiaoming; Hou, Le; Cui, Yayong; Xu, Junhua; Luan, Ping; Zheng, Dong.
Affiliation
  • Chen J; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Zou C; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Guan H; Guangdong Yunzhao Medical Technology Co., Ltd., Guangzhou, China.
  • Zhou X; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Hou L; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Cui Y; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Xu J; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Luan P; School of Basic Medical Sciences, Shenzhen University, Shenzhen, China.
  • Zheng D; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
CNS Neurosci Ther ; 30(7): e14823, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38992870
ABSTRACT

BACKGROUND:

Caloric restriction (CR) might be effective for alleviating/preventing Alzheimer's disease (AD), but the biological mechanisms remain unclear. In the current study, we explored whether CR caused an alteration of gut microbiome and resulted in the attenuation of cognitive impairment of AD animal model.

METHODS:

Thirty-week-old male APP/PS1 transgenic mice were used as AD models (AD mouse). CR was achieved by 30% reduction of daily free feeding (ad libitum, AL) amount. The mice were fed with CR protocol or AL protocol for six consecutive weeks.

RESULTS:

We found that with CR treatment, AD mice showed improved ability of learning and spatial memory, and lower levels of Aß40, Aß42, IL-1ß, TNF-α, and ROS in the brain. By sequencing 16S rDNA, we found that CR treatment resulted in significant diversity in composition and abundance of gut flora. At the phylum level, Deferribacteres (0.04%), Patescibacteria (0.14%), Tenericutes (0.03%), and Verrucomicrobia (0.5%) were significantly decreased in CR-treated AD mice; at the genus level, Dubosiella (10.04%), Faecalibaculum (0.04%), and Coriobacteriaceae UCG-002 (0.01%) were significantly increased in CR-treated AD mice by comparing with AL diet.

CONCLUSIONS:

Our results demonstrate that the attenuation of AD following CR treatment in APP/PS1 mice may result from alterations in the gut microbiome. Thus, gut flora could be a new target for AD prevention and therapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mice, Transgenic / Amyloid beta-Protein Precursor / Caloric Restriction / Alzheimer Disease / Gastrointestinal Microbiome Limits: Animals Language: En Journal: CNS Neurosci Ther Journal subject: NEUROLOGIA / TERAPEUTICA Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mice, Transgenic / Amyloid beta-Protein Precursor / Caloric Restriction / Alzheimer Disease / Gastrointestinal Microbiome Limits: Animals Language: En Journal: CNS Neurosci Ther Journal subject: NEUROLOGIA / TERAPEUTICA Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido